Intercept Pharmaceuticals, Inc. (ICPT)

Nov 8, 2023 - ICPT was delisted (reason: acquired by Alfasigma)

19.00

0.00 (0.00%)

Inactive · Last trade price on Nov 7, 2023

Intercept Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Revenue	317.68	285.71	260.75	233.97	252	179.8
Revenue Growth	14.64%	9.57%	11.45%	-7.16%	40.15%	37.30%
Gross Profit	317.05	284.73	259.55	231.62	247.79	177.29
Operating Income	-55.1	-68.22	-100.69	-217.91	-312.43	-285.49
Net Income	-61.61	221.82	-91.43	-274.88	-344.68	-309.24
Earnings Per Share	-1.48	6.55	-2.87	-8.34	-10.89	-10.86
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cash & Investments	322.71	485.57	419.69	469.67	652.62	436.16
Total Debt	223.86	332.67	539.78	575.51	547.76	371.25
Net Cash (Debt)	98.86	152.89	-120.09	-105.85	104.87	64.91
Net Cash Growth	-34.64%	-	-	-	61.56%	9.57%
Net Cash Per Share	2.37	4.52	-3.77	-3.21	3.31	2.28

Cash Flow & CapEx

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Operating Cash Flow	-63.02	-26.78	-41.07	-171.86	-236.61	-240.71
Capital Expenditures	0.19	-0.57	-0.4	-3.89	-1.14	-0.17
Free Cash Flow	-62.83	-27.35	-41.46	-175.76	-237.75	-240.88
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Gross Margin	99.80%	99.66%	99.54%	98.99%	98.33%	98.60%
Operating Margin	-17.34%	-23.88%	-38.62%	-93.14%	-123.98%	-158.78%
Pretax Margin	-18.09%	-61.20%	-52.29%	-116.85%	-136.78%	-171.99%
Profit Margin	-19.39%	77.64%	-35.06%	-117.48%	-136.78%	-171.99%
FCF Margin	-19.78%	-9.57%	-15.90%	-75.12%	-94.34%	-133.97%

Valuation

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Oct '26 Oct 10, 2026	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
PE Ratio	-	2.31	-	-	-	-
PS Ratio	-	1.79	1.85	3.48	16.10	16.62